Our innovation is: “life-saving, breakthrough, game-changing”
Ondine Biomedical Inc.
What problem is the innovation trying to solve?
"Ondine’s innovation directly targets the global threat of drug resistance. Identified by the World Health Organization as one of the top five human health crises, drug-resistant infections are forecast to cause a staggering 10 million deaths and have a US$100-trillion economic impact annually by 2050: more than cancer, diabetes and cholera combined!"
"Ondine’s Photodisinfection is a patented, light-activated antimicrobial system that kills drug-resistant germs of all kinds in minutes without the use of antibiotics. Already in use at Vancouver General Hospital and UBC Hospital, it has helped prevent hundreds of post-surgical infections and saved millions of dollars annually in avoided infection costs."
© 2018 - Sun Oct 20 08:05:01 UTC 2019 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.